Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The neuropeptide serum (specifically identified as **SkinCeuticals P-TIOX**) is a topical cosmeceutical formulation designed to address both dynamic and static facial wrinkles. Its primary active ingredients include a blend of neuropeptides: **acetyl hexapeptide-8** (Argireline), which inhibits the SNARE complex to reduce acetylcholine release, and **dipeptide diaminobutyroyl benzylamide diacetate** (Syn-Ake), an antagonist of the muscular nicotinic acetylcholine receptor. Together, these peptides work to relax facial muscles and reduce the appearance of expression lines. The serum also contains **polyhydroxy acids (PHA)** for gentle exfoliation, **niacinamide** for skin barrier support, and **laminaria extract**. Clinical data presented at the AAD 2026 meeting demonstrated that twice-daily application significantly improves forehead wrinkles, crow's feet, and overall skin radiance in male subjects over an 8-week period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on neuropeptide serum.